Ekachai Medical Care PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	1,240	1,307	1,209	1,049	1,146
Revenue	1,240	1,307	1,209	1,049	1,146
Revenue Growth (YoY)	-5.15%	8.13%	15.27%	-8.54%	77.52%
Cost of Revenue	721.92	718.76	669.22	609	602.79
Gross Profit	517.7	588.13	539.39	439.51	543.57
Selling, General & Admin	220.77	281.17	223.9	197.33	173.05
Operating Expenses	220.77	281.17	223.9	197.33	173.05
Operating Income	296.94	306.95	315.49	242.18	370.52
Interest Expense	-1.68	-1.91	-1.65	-1.62	-1.81
Interest & Investment Income	24.26	35.62	26.24	17.68	1.37
Earnings From Equity Investments	0	-1.21	-0.07	-	-
Other Non Operating Income (Expenses)	18.32	14.09	13.29	17.55	10.29
EBT Excluding Unusual Items	337.84	353.54	353.3	275.79	380.37
Gain (Loss) on Sale of Investments	-	-	19.5	409.96	44.38
Pretax Income	337.84	353.54	372.8	685.75	424.76
Income Tax Expense	66.4	63.21	70.58	134.86	84.25
Earnings From Continuing Operations	271.44	290.34	302.22	550.89	340.51
Minority Interest in Earnings	-9.14	-10.28	-4.96	0.44	4.32
Net Income	262.3	280.06	297.26	551.32	344.83
Net Income to Common	262.3	280.06	297.26	551.32	344.83
Net Income Growth	-6.34%	-5.79%	-46.08%	59.88%	378.24%
Shares Outstanding (Basic)	816	767	715	677	653
Shares Outstanding (Diluted)	816	767	752	710	657
Shares Change (YoY)	6.39%	2.04%	5.83%	8.22%	0.40%
EPS (Basic)	0.32	0.37	0.42	0.81	0.53
EPS (Diluted)	0.32	0.36	0.40	0.78	0.53
EPS Growth	-11.95%	-7.66%	-49.06%	47.75%	376.28%
Free Cash Flow	-73.69	62.61	280.81	235.31	289.36
Free Cash Flow Per Share	-0.09	0.08	0.37	0.33	0.44
Dividend Per Share	0.300	0.550	0.293	0.305	0.229
Dividend Growth	-45.45%	87.91%	-3.91%	33.13%	127.21%
Gross Margin	41.76%	45.00%	44.63%	41.92%	47.42%
Operating Margin	23.95%	23.49%	26.10%	23.10%	32.32%
Profit Margin	21.16%	21.43%	24.59%	52.58%	30.08%
Free Cash Flow Margin	-5.95%	4.79%	23.23%	22.44%	25.24%
EBITDA	371.5	386.08	394.01	311.92	438.54
EBITDA Margin	29.97%	29.54%	32.60%	29.75%	38.26%
D&A For EBITDA	74.56	79.13	78.52	69.74	68.03
EBIT	296.94	306.95	315.49	242.18	370.52
EBIT Margin	23.95%	23.49%	26.10%	23.10%	32.32%
Effective Tax Rate	19.65%	17.88%	18.93%	19.67%	19.83%
Revenue as Reported	1,258	1,329	1,258	1,491	1,201

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.